Monsanto Co. (NYSE:MON)‘s stock had its “buy” rating restated by equities research analysts at Argus in a report issued on Sunday. They currently have a $128.00 target price on the stock. Argus’ price target would indicate a potential upside of 23.84% from the company’s previous close.
A number of other equities research analysts have also weighed in on the company. BMO Capital Markets reissued an “outperform” rating and issued a $128.00 target price on shares of Monsanto in a research note on Saturday. JPMorgan Chase & Co. set a $128.00 target price on Monsanto and gave the company a “buy” rating in a research note on Thursday. Zacks Investment Research lowered Monsanto from a “hold” rating to a “strong sell” rating in a research report on Friday. Deutsche Bank AG reaffirmed a “buy” rating on shares of Monsanto in a research report on Thursday. Finally, Barclays PLC reaffirmed a “hold” rating and set a $110.00 price target on shares of Monsanto in a research report on Thursday. Three analysts have rated the stock with a sell rating, eight have given a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $114.67.
Shares of Monsanto (NYSE:MON) opened at 103.36 on Friday. The firm has a 50-day moving average price of $104.86 and a 200-day moving average price of $101.43. The firm has a market cap of $45.23 billion, a PE ratio of 45.49 and a beta of 1.19. Monsanto has a 52 week low of $83.73 and a 52 week high of $114.26.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The company earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. During the same quarter in the previous year, the company posted ($0.19) EPS. Monsanto’s revenue for the quarter was up 8.8% on a year-over-year basis. On average, equities research analysts predict that Monsanto will post $4.89 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be issued a dividend of $0.54 per share. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.09%. Monsanto’s payout ratio is 71.05%.
In other news, COO Brett D. Begemann sold 27,980 shares of the stock in a transaction on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Michael K. Stern sold 12,797 shares of the stock in a transaction on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total value of $1,302,350.69. Following the transaction, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.
Several institutional investors have recently added to or reduced their stakes in MON. Candriam Luxembourg S.C.A. bought a new position in shares of Monsanto during the second quarter worth approximately $12,767,000. Nisa Investment Advisors LLC boosted its position in shares of Monsanto by 3.2% in the second quarter. Nisa Investment Advisors LLC now owns 189,692 shares of the company’s stock worth $19,616,000 after buying an additional 5,890 shares in the last quarter. Shell Asset Management Co. boosted its position in shares of Monsanto by 7.7% in the second quarter. Shell Asset Management Co. now owns 131,594 shares of the company’s stock worth $13,608,000 after buying an additional 9,459 shares in the last quarter. Carmignac Gestion bought a new position in shares of Monsanto during the second quarter worth approximately $197,555,000. Finally, Legal & General Group Plc boosted its position in shares of Monsanto by 2.5% in the first quarter. Legal & General Group Plc now owns 1,944,838 shares of the company’s stock worth $170,663,000 after buying an additional 46,878 shares in the last quarter. 79.02% of the stock is currently owned by hedge funds and other institutional investors.